Get the app!
Back to Trades

Adams Kendra

Chief Financial OfficerCIK 0001991929

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
4
Buy transactions
0
Sell transactions
1
Companies
1
Active
2025–2026

Across 4 filings between 2025–2026, Adams Kendra, Chief Financial Officer, has disclosed $173.7K in transactions — all concentrated in C4 Therapeutics, Inc. (CCCC). Their disclosed trades are heavily weighted toward selling — $0 in buys and $122.5K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

4 loaded
Nov 13CCCC
C4 Therapeutics, Inc.
Adams KendraChief Financial OfficerSell$122.5K
Sep 21CCCC
C4 Therapeutics, Inc.
Adams KendraChief Financial OfficerExercise$9.4K
Feb 18CCCC
C4 Therapeutics, Inc.
Adams KendraChief Financial OfficerGrant$32.6K
Sep 19CCCC
C4 Therapeutics, Inc.
Adams KendraChief Financial OfficerExercise$9.2K

4 filings